ERYPEG 75MCG

Price 5340 INR/ Thousand

Get a Price/Quote

MOQ : 5 Vials

ERYPEG 75MCG Specification

Indication
Treatment of symptomatic anemia associated with chronic renal failure including patients on dialysis and those not yet undergoing dialysis

Pacakaging (Quantity Per Box)
1 prefilled syringe per box

Origin of Medicine
Biological

Salt Composition
Methoxy polyethylene glycol-epoetin beta 75 mcg

Dosage Form
Injection (Prefilled Syringe)

Drug Type
Biological/Prescription

Ingredients
Methoxy polyethylene glycol-epoetin beta (Pegylated Erythropoietin)

Physical Form
Injection

Function
Stimulates erythropoiesis (red blood cell production)

Recommended For
Anemia due to chronic kidney disease

Dosage
As directed by the physician

Dosage Guidelines
Administer subcutaneously or intravenously as per medical advice

Suitable For
Adults

Quantity
0.3 ml (1 prefilled syringe)

Storage Instructions
Store between 2C to 8C. Do not freeze. Protect from light.

Therapeutic Class
Hematopoietic agents

Prescription/Non Prescription
Prescription drug

Shelf Life
24 months from manufacturing date

Appearance
Clear, colorless liquid

Brand Name
ERYPEG 75MCG

Administration Route
Subcutaneous or Intravenous

Container Type
Prefilled Syringe

Inactive Ingredients
Polysorbate 20, Sodium dihydrogen phosphate, Sodium chloride, Water for injections

About ERYPEG 75MCG

Erypeg 75mcg Injection is a medicine used in the treatment of anemia due to chronic kidney disease and cancer chemotherapy. It works by stimulating the stem cells of the bone marrow to increase red blood cell production. At the same time, it acts on red blood cells to protect them against destruction.Erypeg 75mcg Injection is generally given by a doctor or a nurse. Do not self-administer this medicine at home. The dose depends on your body weight and the cause of your anemia. Get the injection regularly until you complete the dose. Iron supplements both before and during treatment may make this treatment more effective.The most common side effects of taking this medicine include nausea, vomiting, diarrhea, and fever. It may also cause other side effects. These side effects are most common at the start of treatment but if they persist your doctor may be able to suggest ways of preventing or reducing them.Before using the medicine, tell your doctor if you have uncontrolled high blood pressure, heart disease, or gout (disease of joint pain). You should also tell him/her what other medicines you are taking in case they affect this treatment. Your blood pressure should be checked often during this treatment by you or your doctor. You may also need other regular medical tests to be sure this medicine is not causing harmful effects. It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.

Therapeutic Action

ERYPEG 75MCG actively enhances erythropoiesis, facilitating the increased production of red blood cells in individuals experiencing anemia due to chronic kidney disease. This targeted therapy provides sustained improvement in hemoglobin levels and alleviates fatigue and weakness associated with anemia.

Recommended Usage and Administration

The injection is intended for adult patients and must be administered by a healthcare professional either subcutaneously or intravenously, according to the physician's prescription. Each prefilled syringe contains the recommended single dose for use, supporting accurate and safe drug delivery.

Product Handling and Storage

ERYPEG 75MCG should be stored between 2C and 8C and shielded from light exposure. Freezing must be strictly avoided to preserve the integrity and effectiveness of the medication. Handling and administration should be entrusted to professionals within the medical setting.

FAQ's of ERYPEG 75MCG:

Q: How should ERYPEG 75MCG be administered for treating anemia?

A: ERYPEG 75MCG is given either as a subcutaneous or intravenous injection, strictly following the dosage and instructions provided by the treating physician. It is designed for use in adult patients only.

Q: What is the primary benefit of ERYPEG 75MCG in patients with chronic kidney disease?

A: ERYPEG 75MCG stimulates the body's production of red blood cells to alleviate anemia, helping to improve energy levels and overall quality of life in adults with chronic kidney disease.

Q: When is ERYPEG 75MCG recommended for use?

A: This medication is prescribed for symptomatic anemia associated with chronic renal failure, including patients who are on dialysis and those not yet undergoing dialysis.

Q: Where should ERYPEG 75MCG injections be stored before use?

A: The prefilled syringe should be stored inside its original packaging at temperatures between 2C and 8C, protected from light and never frozen, to ensure its potency and safety.

Q: What is the process for receiving ERYPEG 75MCG treatment?

A: Administration of ERYPEG 75MCG requires prescription by a qualified physician. The injection is performed in a controlled healthcare setting by a trained professional, following individual patient assessments.

Q: Does ERYPEG 75MCG contain any inactive ingredients apart from the main active component?

A: Yes, besides Methoxy polyethylene glycol-epoetin beta, the formulation includes polysorbate 20, sodium dihydrogen phosphate, sodium chloride, and water for injections as inactive ingredients.

Q: What should be done if a dose of ERYPEG 75MCG is missed?

A: If a dose is missed, notify your healthcare provider as soon as possible. Do not administer an additional dose on your own; follow your physician's instructions regarding dosing adjustments.

Tell us about your requirement